衰老和衰老:大脑瘤进展和药物耐药性的关键因素

相关实验视频

Updated: May 23, 2025

Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry

Published on: April 6, 2022

3.4K

Chao Zhang¹, Neha², Jiaqi Zhang³

¹Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

|March 11, 2025

概括

衰老显著影响脑瘤的发展和治疗耐药性,特别是在质母细胞瘤. 了解这些与年龄相关的分子变化对于开发针对老年患者的有效疗法至关重要.

科学领域:

神经瘤学神经瘤学
老年学是一门学科.
分子生物学分子生物学

背景情况:

衰老是脑瘤发展,进展和治疗耐药性的关键因素,特别是在质母细胞瘤 (GBM) 中.
全球预期寿命的增加与脑瘤的发病率更高相关,使年龄成为一个重要的预后指标.
衰老过程和脑瘤生物学之间的分子相互作用是复杂的,需要进行详细的研究.

研究的目的:

审查将衰老与脑瘤进展联系在一起的分子机制,重点关注质母细胞瘤.
探索与年龄相关的基因突变,细胞路径改变和瘤微环境变化如何影响瘤发生和治疗耐药性.
讨论当前治疗挑战和老年脑瘤患者的新兴策略.

主要方法:

文献综述专注于将衰老和脑瘤连接起来的分子机制.
分析与年龄相关的基因突变,细胞通路 (例如PI3K/AKT/mTOR,p53,EGFR/PTEN) 和瘤微环境.
对老年患者的治疗策略和临床试验数据的检查.

主要成果:

衰老通过遗传突变,改变细胞路径和修改的瘤微环境,有助于大脑瘤的发展.
像PI3K/AKT/mTOR,p53和EGFR/PTEN这样的关键信号通路在老化和脑瘤中经常受到失调,影响进展和抵抗.
对老年患者的治疗策略通常受到临床试验代表性不足和并发性疾病的限制,这凸显了对特定年龄的方法的需求.

结论:

衰老与脑瘤生物学密切相关,影响瘤的开始,生长和对治疗的反应.
向疗法和免疫疗法对解决脑瘤中与年龄相关的分子变化有前途.
个性化治疗策略和进一步的研究对于改善老年脑瘤患者的临床管理和生活质量至关重要.

关键词:

衰老的衰老衰老的衰老自自是一种自的过程.在GBMGBMGBMGBMGBM 遗传变化和免疫学变化突触性可塑性突触性可塑性治疗干预措施治疗干预这是一个小RNARNA.

相关概念视频

02:56

Treatment Resistant Cancers

3.2K

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

3.2K

02:07

Tumor Progression

6.2K

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

6.2K

02:53

Adaptive Mechanisms in Cancer Cells

5.7K

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

5.7K

01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...

02:40

Cancer Stem Cells and Tumor Maintenance

4.7K

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

4.7K

03:03

mTOR Signaling and Cancer Progression

3.7K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...